Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Abstract The 5-2-1 criteria was developed to facilitate the identification and referral of patients with Parkinson’s Disease (PD) inadequately controlled by oral medications. The criterion was not developed to screen patients with PD for device-aided therapy eligibility. The robust design and valida...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Angelo Antonini, K. Ray Chaudhuri, Josefa Domingos, Joohi Jimenez-Shahed, Jack Wright, Connie H. Yan, Ali Alobaidi, Lars Bergmann, Koray Onuk, Linda Harmer, Irene A. Malaty
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-07-01
Saila:	BMC Neurology
Gaiak:	Advanced Parkinson’s disease Device-aided therapies Patient identification 5-2-1 criteria Screening performance
Sarrera elektronikoa:	https://doi.org/10.1186/s12883-024-03691-3
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!